Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000914190-13-000111
Filing Date
2013-01-29
Accepted
2013-01-29 16:15:14
Documents
1
Period of Report
2013-01-25

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4  
1 PRIMARY DOCUMENT edgar.xml 4 12468
  Complete submission text file 0000914190-13-000111.txt   14030
Mailing Address 2207 BRIDGEPOINTE PARKWAY SUITE 250 SAN MATEO CA 94404
Business Address 2207 BRIDGEPOINTE PARKWAY SUITE 250 SAN MATEO CA 94404 650-588-6404
Talon Therapeutics, Inc. (Issuer) CIK: 0001140028 (see all company filings)

EIN.: 320064979 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 3595 JOHN HOPKINS COURT SAN DIEGO CA 92121
Business Address
MAIER PAUL V (Reporting) CIK: 0001182615 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-32626 | Film No.: 13555579